SNY Sanofi

$42.77▲ +0.12% Healthcare Other
After hours $42.75▼ -0.05% Sep 11, 7:38 PM ET
Volume 2.37M Avg Volume (10D) 2.08M
Key Metrics & Fundamentals
Market Cap
$102.48B
P/E Ratio
22.8
Div Yield
5.66%
52W Range
40.89 - 52.68
% vs 50 MA
-2.64%
% vs 200 MA
-6.21%
RSI-14
36.4
MACD Histogram
-0.3100
Beta (1Y vs SPY)
0.35
Free Cash Flow
$2.96B
Gross Rev
$12.30B
Gross Profit
$9.28B
EBITDA
$3.01B
COGS
$3.02B
Operating Exp
$6.90B
Operating Income
$2.38B
EBIT
$2.38B
Pretax Income
$837.00M
Net Income
$343.00M
EPS (Diluted)
0.15
Price & Volume History
Loading chart…
Recent News
Regeneron Eyes 2026 Catalysts as EYLEA HD and DUPIXENT Drive Growth
MarketBeat · Sep 12, 2026 7:02 AM
Sanofi: Information concerning the total number of voting rights and shares - August 2026
GlobeNewswire · Sep 11, 2026 4:30 PM
Could Remibrutinib Become the Next $9 Billion Drug for Novartis?
Insider Monkey · Sep 11, 2026 12:44 AM
Novavax Highlights Sanofi, Pfizer Catalysts in Matrix-M Platform Pivot
MarketBeat · Sep 10, 2026 6:02 PM
Sanofi partners with USA Pickleball to launch "Serve Up Protection" campaign to help protect older adults from COVID-19 with NUVAXOVID™
PR Newswire · Sep 10, 2026 1:00 PM
REZUROCK (Belumosudil) Sales Forecast and Market Size Analysis 2020-2025 & 2026-2034
GlobeNewswire · Sep 10, 2026 10:23 AM
Novavax Highlights Matrix-M Licensing Push, Oncology Ambitions at Cantor Conference
MarketBeat · Sep 10, 2026 5:02 AM
IPO Stock LB Pharma Has Tripled In Under A Year. Is It A Takeover Target?
Investor's Business Daily · Sep 9, 2026 12:00 PM
RBC Initiates Sanofi at Sector Perform With EUR80 Price Target
MT Newswires · Sep 9, 2026 10:31 AM
Sanofi and Keke Palmer team up to urge parents to help protect babies from serious RSV with BEYFORTUS®
PR Newswire · Sep 8, 2026 12:00 PM
Financial Overview - Income Statement Quarterly

See SNY's money flow as a full page

Social Sentiment
Avg +0.57 · 3 posts
NewsDiscussionSNY Puts
r/wallstreetbets · Sep 9, 2025
The post frames SNY as a potential target for lawsuits due to their continued production of Td vaccine, indicating concern about legal risk.
negative +0.60
NewsTradeRFK Jr. Just Nuked mRNA Funding, Here’s Why Biotech Bags Are About to Get Heavy 💉📉
r/wallstreetbets · Aug 11, 2025
Similar potential to NVAX and GSK.
positive +0.30
NewsIt’s the kind of day I particularly enjoy, as some sectors are showing strength across the board. Today, it’s clear that healthcare, energy, and consumer cyclicals are leading the charge, with companies like SNY (+0.95%) and EQNR (+1.56%) making noticeable moves.
r/StockMarket · Dec 27, 2024
The post explicitly highlights SNY's positive performance.
positive +0.80
AI Analysis

Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.

Not financial advice. All data, scores, charts, and analysis on this site are provided for informational and educational purposes only and do not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. See our Legal Notice for full details.
An unhandled error has occurred. Reload 🗙